21/10/2022
In the field of Rare Diseases and Orphan Drugs , I work with and support drug developer companies in all matters where quality of life and life span are under threat and urgent access to treatment is required ;
Under the Managed Access Program Title;
• Early Access Programs,
• Expanded Access Programs,
• Named Patient Programs,
• Compassionate Use,
I find solutions to complex business relationships and manage end-to-end on behalf of companies.
Everything ; For Our Rare Patients Fighting Rare Diseases...
A hope for rare patients to reach the cure; I will continue to cooperate with our physicians and developer pharmaceutical companies to increase treatment options and improve the success of their treatments.
You only need to take one step to work with us.
Collaborate with Us to Support Patients in Turkey battling deadly Rare Diseases and Doctors striving to cure them
Please have a look at my profil and website below
* Rare Diseases, Ultra Rare Diseases, Orphan Drugs
* Compassionate Use (CU)
* Named Patient Programs (NPP)
* Early Access Programs (EAPs)
* Expanded Access Programs (EAPs)
* Named Patient Import (NPI)
* First Launch Spark of the Medicine/Drug and Market Access
* On behalf of the Developer Company / Turkey Start of the Drug/Medicine
* Formation of the Key Advisory Board , Key Opinion Leaders (KOLs)
* Key Account Management (KAM)
* Business Consultant
* Sales & Marketing
* Relations between the Turkish Ministry of Health and TITCK
* Creating Advisory Boards
* Pre-launch preparation
* Establishing Advisory Boards for clinical studies
* Distributorship and end-to-end business relations
* Pre-launch meeting preparations and congresses
* Customs procedures of Orphan Drugs
* Ex*****on of relations between Turkish Ministry of Health, TITCK on behalf of the company
* Managing relations with the Turkish Pharmacists Association (TEB) on behalf of the company
* Organization of launch meetings on behalf of the company and organization of clinical meeting meals
* Participation in Congresses on behalf of the developer or parent company
* Selection of the most suitable CRO companies, Clinics and study centers for Clinical Trials
* Organization of Patient Selection suitable for Clinical Studies
* Establishment of all units and organization including sales and marketing on behalf of the Developer Pharmaceutical Company, Country branch management on behalf of the company
* Management, Sales Support and Distributorship
Fatih AKTAŞ
Country Manager / at BiotchPharma Pharmaceutical
✉️[email protected]
Fatih AKTAŞ
BiotchPharma Pharmaceutical Sales-Marketing and Consulting Services
